JAMA. Published online December 6, 2021. doi:10.1001/jama.2021.22619
On December 1, JAMA convened a panel of experts to discuss what’s known—and unknown—about Omicron, the newest SARS-CoV-2 variant of concern. JAMA Associate Editor Preeti Malani, MD, MSJ, a professor of medicine in the Division of Infectious Diseases at the University of Michigan Medical School and the university’s chief health officer, hosted the panel. Joining her were Adam Lauring, MD, PhD, an associate professor of medicine in the university’s Division of Infectious Diseases, and Carlos del Rio, MD, a distinguished professor of medicine in the Division of Infectious Diseases at Emory University School of Medicine, a professor of epidemiology and global health at the Rollins School of Public Health, and a member of JAMA’s editorial board. The following is an edited version of their conversation.
Comments